CARDIOVASCULAR PREVENTION / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
This study sought to use the latest Life’s Essential 8 scoring tool to obtain information on the relationship between serum vitamin D concentration and adolescent cardiovascular health (CVH).

Material and methods:
A total of 1,819 teenagers aged 16–19 were enrolled. Associations between serum vitamin D concentrations and CVH ratings were estimated using multiple linear regression and multinomial logistic regression methods, and the dose-response relationship was examined by restricted cubic spline analysis.

Results:
After adjusting for all confounding factors, serum vitamin D concentrations were positively correlated with CVH scores (β = 0.12; 95% CI: 0.09–0.14, p < 0.001). Among the sex and race subgroups, the correlation was stronger in male, Mexican American and Non-Hispanic Black participants, with odds ratios (ORs) of 1.05 (95% CI: 1.03–1.07), 1.06 (95% CI: 1.04–1.08), p = 0.002), 1.07 (95% CI: 1.03–1.11), 1.09 (95% CI: 1.05–1.14), p = 0.01, 1.04 (95% CI: 1.01–1.06), and 1.05 (95% CI: 1.02–1.09), p = 0.01, respectively. Serum vitamin D concentrations had a nonlinear relationship with CVH ratings. CVH scores grew with serum vitamin D concentrations up to the inflection point (86 nmol/l) (β = 0.17 (95% CI: 0.135–0.206, p < 0.001). When serum vitamin D concentrations exceeded 86 nmol/l, CVH scores were not associated with serum vitamin D concentrations.

Conclusions:
The study identified a nonlinear relationship between serum vitamin D levels and CVH in US adolescents aged 16–19, with an inflection point at 86 nmol/l. These findings underscore the importance of vitamin D in adolescent CVH and suggest the need for targeted health strategies, particularly in high-risk groups such as male, Mexican American, and Non-Hispanic Black teenagers.
REFERENCES (33)
1.
Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US ch ildren: NHANES 2001-2004. Pediatrics 2009; 124: e362-70.
 
2.
Kim YS, Hwang JH, Song MR. The association between vitamin D deficiency and metabolic syndrome in korean adolescents. J Pediatr Nurs 2018; 38: e7-11.
 
3.
Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis 2013; 57: 392-7.
 
4.
Muehleisen B, Gallo RL. Vitamin D in allergic disease: shedding light on a complex problem. J Allergy Clin Immunol 2013; 131: 324-9.
 
5.
Riverin BD, Maguire JL, Li P. Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis. PLoS One 2015; 10: e0136841.
 
6.
Wolters M, Marron M, Foraita R, et al. Longitudinal associations between vitamin D status and cardiometabolic risk markers among children and adolescents. J Clin Endocrinol Metabolism 2023; 108: e1731-42.
 
7.
Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Im pact Goal through 2020 and beyond. Circulation 2010; 121: 586-613.
 
8.
Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation 2022; 146: e18-43.
 
9.
Petermann-Rocha F, Deo S, Celis-Morales C, et al. An opportunity for prevention: associations between the Life’s Essential 8 Score and cardiovascular incidence using prospective data from UK Biobank. Curr Probl Cardiol 14 2022; 48: 101540.
 
10.
Bundy JD, Zhu Z, Ning H, et al. Estimated Impact of achieving optimal cardiovascular health among US adults on cardiovascular disease events. J Am Heart Assoc 2021; 10: e019681.
 
11.
Ning N, Zhang Y, Liu Q, et al. American Heart Association’s new ‘Life’s Essential 8’ score in association with cardiovascular disease: a national cross-sectional analysis. Public Health 2023; 225: 336-42.
 
12.
Pedamallu H, Zmora R, Perak AM, Allen NB. Life course cardiovascular health: risk factors, outcomes, and interventions. Circ Res 2023; 132: 1570-83.
 
13.
Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012; 32: 2794-802.
 
14.
Mazidi M, Mikhailidis DP, Banach M, Dehghan A. Impact of serum 25-hydroxyvitamin D 25(OH) on telomere attrition: a Mendelian randomization study. Clin Nutr 2020; 39: 2730-3.
 
15.
Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-86.
 
16.
Munns CF, Shaw N, Kiely M, et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 2016; 101: 394-415.
 
17.
Rabenberg M, Scheidt-Nave C, Busch MA, et al. Implications of standardization of serum 25-hydroxyvitamin D data for the evaluation of vitamin D status in Germany, including a temporal analysis. BMC Public Health 2018; 18: 845.
 
18.
Williams BD, Churilla JR. Ultra-processed food intake in U.S. adolescents: national public health implications. J Adolesc Health 2022; 70: 173-4.
 
19.
Wimalawansa SJ. Vitamin D and cardiovascular diseases: causality. J Steroid Biochem Mol Biol 2018; 175: 29-43.
 
20.
Lu S, Guo S, Hu F, et al. The associations between the polymorphisms of vitamin D receptor and coronary artery disease: a systematic review and meta-analysis. Medicine 2016; 95: e3467.
 
21.
Fronczek M, Osadnik T, Banach M. Impact of vitamin D receptor polymorphisms in selected metabolic disorders. Curr Opin Clin Nutr Metab Care 2023; 26: 316-22.
 
22.
Liu Y, Guo X, Huang SY, et al. Evaluation of association studies and a systematic review and meta-analysis of VDR polymorphisms in type 2 diabetes mellitus risk. Medicine 2021; 100: e25934.
 
23.
Faridi KF, Lupton JR, Martin SS, et al. Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk. Arch Med Sci 2017; 13: 732-7.
 
24.
Faghfouri AH, Faghfuri E, Maleki V, Payahoo L, Balmoral A, Khaje Bishak Y. A comprehensive insight into the potential roles of VDR gene polymorphism in obesity: a systematic review. Arch Physiol Biochem 2022; 128: 1645-57.
 
25.
Ilinčić B, Stokić E, Stošić Z, et al. Vitamin D status and circulating biomarkers of endothelial dysfunction and inflammation in non-diabetic obese individuals: a pilot study. Arch Med Sci 2017; 13: 53-60.
 
26.
Manojlovic M, Ilincic B, Naglic DT, et al. Association between vitamin D hypovitaminosis and severe forms of COVID-19. Eur Rev Med Pharmacol Sci 2023; 27: 5318-26.
 
27.
Reis JP, von Mühlen D, Miller ER 3rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009; 124: e371-9.
 
28.
Chen TC, Chimeh F, Lu Z, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 2007; 460: 213-7.
 
29.
Tirabassi G, Cutini M, Salvio G, Cerqueni G, Lenzi A, Balercia G. Influence of vitamin D levels on the cardiovascular profile of hypogonadal men. J Endocr Invest 2017; 40: 1007-14.
 
30.
Beveridge LA, Witham MD. Vitamin D and the cardiovascular system. Osteoporosis Int 2013; 24: 2167-80.
 
31.
Durup D, Jørgensen HL, Christensen J, et al. A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD Study. J Clin Endocrinol Metab 2015; 100: 2339-46.
 
32.
Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocr Metab 2012; 97: 2644-52.
 
33.
Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019; 380: 33-44.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top